{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:51:28Z","timestamp":1792065088041,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1136\/ard.2006.051391","type":"journal-article","created":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T00:24:45Z","timestamp":1144715085000},"page":"845-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":379,"title":["Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review"],"prefix":"10.1016","volume":"65","author":[{"given":"J","family":"Avouac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.051391_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1136\/ard.2006.051391_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.051391_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/03009749509095163","article-title":"The value of the ACR 1987 criteria in very early rheumatoid arthritis","volume":"24","author":"Kaarela","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib4","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1529-0131(200111)44:11<2485::AID-ART428>3.0.CO;2-S","article-title":"Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later","volume":"44","author":"Saraux","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"suppl 17","key":"10.1136\/ard.2006.051391_bib5","first-page":"S15","article-title":"Prognostic criteria in rheumatoid arthritis: can we predict which patients will require specific anti-rheumatoid treatment?","volume":"15","author":"Kirwan","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/ar395","article-title":"Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value","volume":"4","author":"van Boekel","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.2006.051391_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2006.051391_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/ard.2005.038851","article-title":"The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis","volume":"65","author":"Chen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.rhu.0000164818.98410.2f","article-title":"Antibodies to cyclic citrullinated peptide in patients with chronic arthritis attending an arthritis-monitoring clinic","volume":"11","author":"Limaye","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib10","first-page":"197","article-title":"The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis","volume":"12","author":"Shovman","year":"2005","journal-title":"Clin Dev Immunol"},{"key":"10.1136\/ard.2006.051391_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/03009740510026634","article-title":"Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population","volume":"34","author":"Kwok","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1515\/CCLM.2005.214","article-title":"Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis","volume":"43","author":"Fernandez-Suarez","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1136\/ard.2006.051391_bib13","first-page":"1120","article-title":"Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis","volume":"97","author":"Samanci","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"10.1136\/ard.2006.051391_bib14","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2005.035444","article-title":"Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?","volume":"64","author":"Gao","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib15","first-page":"475","article-title":"A retrospective study of the fluctuation in serum levels of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis","volume":"23","author":"Aotsuka","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1313.031","article-title":"Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis","volume":"1050","author":"Greiner","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1136\/ard.2006.051391_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1196\/annals.1313.033","article-title":"Clinical utility of the anti-CCP assay: experiences with 700 patients","volume":"1050","author":"Sauerland","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1136\/ard.2006.051391_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3346\/jkms.2005.20.3.473","article-title":"Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis","volume":"20","author":"Choi","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1136\/ard.2006.051391_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10067-005-1104-y","article-title":"Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sj\u00c3\u00b6gren\u00e2\u20ac\u2122s syndrome, and Wegener\u00e2\u20ac\u2122s granulomatosis","volume":"24","author":"Kamali","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib20","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib21","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/ard.2004.035089","article-title":"A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis","volume":"64","author":"van Gaalen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cccn.2004.11.025","article-title":"Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients","volume":"354","author":"Garcia-Berrocal","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1136\/ard.2006.051391_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.patbio.2004.04.019","article-title":"Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis","volume":"53","author":"Dubrous","year":"2005","journal-title":"Pathol Biol (Paris)"},{"key":"10.1136\/ard.2006.051391_bib24","first-page":"231","article-title":"Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis","volume":"32","author":"Raza","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ard.2004.029389","article-title":"Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis","volume":"64","author":"Nielen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib26","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"Ronnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00296-004-0571-9","article-title":"Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment","volume":"26","author":"Caramaschi","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2006.051391_bib28","first-page":"131","article-title":"Anti-CCP: history and its usefulness","volume":"12","author":"Herold","year":"2005","journal-title":"Clin Dev Immunol"},{"key":"10.1136\/ard.2006.051391_bib29","doi-asserted-by":"crossref","first-page":"R592","DOI":"10.1186\/ar1719","article-title":"Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis","volume":"7","author":"Boire","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.051391_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/08916930400011965","article-title":"Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA","volume":"37","author":"Bongi","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1136\/ard.2006.051391_bib31","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.20659","article-title":"Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.051391_bib32","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/ar1173","article-title":"Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment","volume":"6","author":"Bobbio-Pallavicini","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.051391_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2003.008623","article-title":"Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases","volume":"63","author":"Dubucquoi","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib34","first-page":"U1097","article-title":"Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis","volume":"117","author":"Solanki","year":"2004","journal-title":"N Z Med J"},{"key":"10.1136\/ard.2006.051391_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","article-title":"Prognostic laboratory markers of joint damage in rheumatoid arthritis","volume":"64","author":"Lindqvist","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib36","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014647","article-title":"Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement","volume":"63","author":"Alessandri","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib38","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","article-title":"Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)","volume":"63","author":"Kastbom","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib39","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/ard.2003.019877","article-title":"Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis","volume":"63","author":"Vallbracht","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/03009740310004856","article-title":"Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity","volume":"33","author":"Soderlin","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib41","first-page":"127","article-title":"Is anti cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?","volume":"36","author":"Girelli","year":"2004","journal-title":"Allerg Immunol (Paris)"},{"key":"10.1136\/ard.2006.051391_bib42","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar1041","article-title":"Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement","volume":"6","author":"Bombardieri","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.051391_bib43","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.051391_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7705\/biomedica.v24i2.1260","article-title":"Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1","volume":"24","author":"Correa","year":"2004","journal-title":"Biomedica"},{"key":"10.1136\/ard.2006.051391_bib46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/03009740410005403","article-title":"Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis","volume":"33","author":"Grootenboer-Mignot","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/rheumatology\/keh143","article-title":"Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica","volume":"43","author":"Lopez-Hoyos","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.051391_bib48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2004.02341.x","article-title":"Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis","volume":"135","author":"Vittecoq","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2006.051391_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03009740310003677","article-title":"High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis","volume":"32","author":"Suzuki","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.62.9.870","article-title":"Clinical utility of the anti-CCP assay in patients with rheumatic diseases","volume":"62","author":"Lee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-139-3-200308050-00021","article-title":"Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis","volume":"139","author":"Pinheiro","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2006.051391_bib52","first-page":"34","article-title":"Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies","volume":"21","author":"Vasishta","year":"2002","journal-title":"Am Clin Lab"},{"key":"10.1136\/ard.2006.051391_bib53","first-page":"2535","article-title":"Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis","volume":"30","author":"Saraux","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib54","first-page":"1691","article-title":"The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis","volume":"30","author":"Jansen","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib55","first-page":"1451","article-title":"Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis","volume":"30","author":"Zeng","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","article-title":"Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis","volume":"42","author":"Bas","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.051391_bib57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","article-title":"Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis","volume":"62","author":"Vencovsky","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib59","first-page":"2074","article-title":"Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis","volume":"29","author":"Jansen","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib60","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/rheumatology\/41.7.809","article-title":"Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors","volume":"41","author":"Bas","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.051391_bib61","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","article-title":"Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis","volume":"47","author":"Bizzaro","year":"2001","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2006.051391_bib62","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","article-title":"Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset","volume":"2","author":"Goldbach-Mansky","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.2006.051391_bib63","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.051391_bib64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.051391_bib65","first-page":"689","article-title":"The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis","volume":"17","author":"van Jaarsveld","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib66","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2004.032177","article-title":"Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis","volume":"64","author":"Vander Cruyssen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib67","first-page":"511","article-title":"Antibodies to cyclic citrullinated peptides in psoriatic arthritis","volume":"32","author":"Bogliolo","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib68","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.2004.029603","article-title":"Anti-cyclic citrullinated peptide antibodies in patients with primary Sjogren\u00e2\u20ac\u2122s syndrome","volume":"64","author":"Tobon","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj\u00c3\u00b6gren\u00e2\u20ac\u2122s syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib70","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/art.20355","article-title":"Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia","volume":"50","author":"Wener","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.051391_bib71","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/keg268","article-title":"Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis?","volume":"42","author":"Salvador","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.051391_bib72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.60.1.67","article-title":"Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"60","author":"Mediwake","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.051391_bib73","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.051391_bib74","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","article-title":"A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis","volume":"6","author":"Berglin","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.051391_bib75","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.051391_bib76","first-page":"S69","article-title":"The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis\u00e2\u20ac\u201da systematic review","volume":"23","author":"Riedemann","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2006.051391_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1573397052954208","article-title":"Anti-CCP antibody detection facilitates early diagnosis and prognosis of rheumatoid arthritis","volume":"1","author":"Pruijn","year":"2005","journal-title":"Curr Rheumatol Rev"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724201096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724201096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.051391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:37:20Z","timestamp":1737351440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724201096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0003496724201096"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.051391","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.051391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Copyright 2006 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}